Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma
Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma
The purpose of this study is to compare once and twice daily GW685698 in asthma
Key Inclusion Criteria:

 -  Clinical diagnosis of Asthma

 -  Reversibility ≥ 12% and ≥200mls reversibility of FEV1 within approximately 30-minutes
 following 2 to 4 puffs of albuterol

 -  FEV1 between 40-85% predicted

 -  Currently on short acting beta2 agonist therapy

 Key Exclusion Criteria:

 -  History of life threatening asthma

 -  Respiratory Infection or oropharyngeal candidiasis

 -  Asthma exacerbation

 -  Uncontrolled disease or clinical abnormality

 -  Allergies

 -  Taking another Investigational medications or other prohibited medications